ArticleToxics2026
Accelerating Cosmetic Innovation Through Next-Generation Computational Toxicology: From Structural Alerts to Molecular Dynamics and Artificial Intelligence for Skin Sensitization Assessment.
Article in Toxics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Skin sensitization remains a critical toxicological endpoint in cosmetic ingredient development, particularly under accelerated innovation cycles and increasingly stringent safety requirements. Although NAMs have achieved substantial regulatory maturity for this endpoint, most computational approaches-including structural alerts, read-across, and quantitative structure-activity relationship models-rely predominantly on chemical structure and statistical associations, with limited representation of the molecular processes underlying sensitization. This perspective proposes a transparent and testable computational framework that integrates conventional chemical descriptors, reaction-domain information, covalent docking, molecular dynamics simulations, and machine learning methods. The framework is organized around the skin sensitization adverse outcome pathway and focuses on generating mechanistically informed descriptors associated with the molecular initiating event and selected molecular processes related to keratinocyte activation. These descriptors include reactive geometry, residue accessibility, interaction persistence, conformational behavior, and perturbation hypotheses involving the KEAP1-NRF2 regulatory axis. Rather than replacing established experimental NAMs or DAs, the proposed workflow is intended as a complementary, tiered evidence layer for the early prioritization of structurally characterized cosmetic ingredients and for guiding subsequent experimental testing. Its future value will depend on module-level validation, demonstration of incremental predictive performance, explicit applicability-domain and uncertainty assessment, computational scalability, and prospective comparison with established NAM outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.